Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Xu Liu, Yuan Zhang, Kun-Yu Yang, Ning Zhang, Feng Jin, Guorong Zou, Xiao-Dong Zhu, Fang-Yun Xie, Xiaoyu Liang, Wen-Fei Li, Zhen‐Yu He, Nian-Yong Chen, Wei-Han Hu, Haijun Wu, Mei Shi, Guan-Qun Zhou, Yan-Ping Mao, Rui Guo, Rui Sun, Jing Huang, Shaoqiang Liang, Wei-Li Wu, Zhen Su, Ling Li, Ping Ai, Yu-Xiang He, Jian Zang, Lei Chen, Li Lin, Shao Hui Huang, Lei Cheng, Jia-Wei Lv, Ying-Qing Li, Shu-Bin Hong, Yusheng Jie, Hao Li, Sai-Wei Huang, Ye‐Lin Liang, Yaqin Wang, Ying-Lin Peng, Jinhan Zhu, Sheng-Bing Zang, Song-Ran Liu, Qingguang Lin, Hao-Jiang Li, Li Tian, Li-Zhi Liu, Hong-Yun Zhao, Aihua Lin, Ji-Bin Li, Na Liu, Ling-Long Tang, Yu-Pei Chen, Ying Sun, Jun Ma